Skin Antiseptic Market Expected to Reach $3,060.81 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Skin Antiseptic Market," The skin antiseptic market size was valued at $1,484.28 million in 2021 and is estimated to reach $3,060.81 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031. Skin antiseptic market analysis from 2021 to 2031 to identify the prevailing skin antiseptic market opportunity. The major factors that drive the growth of skin antiseptic market size are increase in number of surgeries, surge in prevalence of hospital acquired infections (HAIs) and rise in awareness regarding infection control measures.

Increase in number of surgical procedures being performed worldwide drives the demand for skin antiseptics, as these products are used to reduce the risk of infections during surgical procedures. For instance, according to an article published by National Library of Medicine in 2020, about 40 to 50 million surgeries in U.S. and 20 million in Europe are carried out every year. Thus, rise in prevalence of surgeries is expected to drive the growth of the skin antiseptic market share.

In addition, surgical procedures can increase the risk of surgical site infections (SSIs), which occur at the site of a surgical incision. Skin antiseptics play a crucial role in preventing surgical site infections (SSIs), by reducing the number of microorganisms on the skin surface before a surgical procedure, thereby driving the growth of the skin antiseptic market trends.

In addition, rise in the number of hospital-acquired infections (HAIs) is anticipated to drive the growth of skin antiseptic market share. The incidence of HAIs has been increasing in recent years, owing to the emergence of antibiotic-resistant bacteria and other factors. This has led to a growth in demand for skin antiseptics in healthcare facilities, as they are a key component of infection prevention and control programs. Moreover, rise in awareness about hospital acquired infections (HAIs) and increased access to healthcare services have contributed to the growth of the skin antiseptic market.

Furthermore, rise in regulatory approvals for skin antiseptics is expected to drive the growth of market during the skin antiseptic market forecast. For instance, in April 2019, Becton, Dickinson and Company, a leading global medical technology company, received U.S.

Food and Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the U.S. Thus, rise in number of product approval for skin antiseptics is expected to drive the growth of market.

Moreover, adoption of strategies such as acquisition and agreement by key players of market is anticipated to fuel the growth of market. For instance, in September 2022, schülke Group acquired Spanish company ‘Vesismin Health’, based in Barcelona, to provide chlorhexidine-based antiseptics and strengthen its presence in Southern Europe. Thus, adoption of such strategies by key players of market propels market expansion.

In addition, implementation of infection control guidelines and adoption of skin antiseptic during various surgical procedures are expected to contribute to growth of market. Furthermore, as healthcare providers increasingly recognize the importance of infection prevention and control in improving patient outcomes, the demand for skin antiseptics is likely to drive the market growth. However, side effects associated with skin antiseptics and availability of alternative products restrains the growth of skin antiseptic market.

On the basis of type, the market is categorized into alcohol, chlorhexidine, iodine, and others. The alcohol segment accounted for the largest share in terms of revenue in 2021 and is expected to witness highest CAGR during the forecast period, owing to increased usage of alcohol skin antiseptics during surgical procedures and rise in number of key players offering alcohol-based skin antiseptic. In addition, alcohol-based skin antiseptic is effective against wide range of microbes, thereby are highly adopted as compared to other skin antiseptic.

On the basis of form, the skin antiseptic industry is categorized into solutions, cream, swab sticks, and others. The solution segment accounted for the largest share in terms of revenue in 2021 owing to wide availability of antiseptic solution and increase in adoption of antiseptic solutions in pre-operation and pre-injection skin preparation. The others segment is projected to register highest CAGR during the forecast period owing to rise in adoption of other forms of antiseptic such as wipe skin antiseptic during surgeries and number of key players offering wipe and soap form of skin antiseptic.

On the basis of distribution channel, the skin antiseptic industry is categorized into hospital pharmacies, drug stores & retail pharmacies, and online providers. The drug stores and retail pharmacies segment occupied the highest share in 2021 and is expected to remain dominant during forecast period owing to accessibility of retail pharmacies everywhere and large chain of distribution networks.  The online providers segment is projected to register highest CAGR during the forecast period owing to rise in popularity of online pharmacy and number of users preferring online pharmacies.

Region wise, North America accounted for the largest share in terms of revenue in 2021 and is expected to remain dominant during the forecast period owing to rise in number of surgical procedures and presence of major players offering skin antiseptic. In addition, rise in prevalence of hospital acquired infections (HAIs) such as central line-associated bloodstream infections (CLABSIs) are expected to drive the market.

However, Asia-Pacific is anticipated to witness notable growth, owing to rise in implementation of infection control measures, surge in number of surgical site infections, and availability of wide range of skin antiseptic products, thereby driving the growth of market during the forecast period.

Key Finding of The Study

• On the basis of type, the alcohol segment dominated the market in terms of revenue in 2021.
• On the basis of form, solutions segment dominated the market in terms of revenue in 2021.
• On the basis of distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2021. However, the online providers segment is anticipated to grow at the highest CAGR during the forecast period.
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.